Contracts › 75N93019C00045
75N93019C00045: To Identify Novel Adjuvant Candidates That Can Be Used to Augment the Efficacy of Human Vaccines.
Awarded to University of Montana by National Institutes of Health (NIH).
$18.5Mobligated
$18.5Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93019C00045 |
|---|---|
| Awardee | University of Montana |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MT |
| Offers received | 12 |
| Period of performance | 06 September 2019 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record